Dr. Cherian Karunapuzha
Neurology · Oklahoma City, OK
CMS Profile ID: 358498 · NPI: 1881896397
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$518,605
Number of Payments
596
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $380,654 |
| Travel and Lodging | $55,585 |
| Honoraria | $41,109 |
| Consulting Fee | $30,486 |
| Food and Beverage | $10,192 |
| Education | $579 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $163,613 |
| Neurocrine Biosciences, Inc. | $100,711 |
| ACADIA Pharmaceuticals Inc | $72,234 |
| Amneal Pharmaceuticals LLC | $56,447 |
| ABBVIE INC. | $47,170 |
| MDD US Operations, LLC | $38,153 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?